Sara Tartof to California
This is a "connection" page, showing publications Sara Tartof has written about California.
Connection Strength
1.279
-
Development and validation of a prediction algorithm to identify birth in countries with high tuberculosis incidence in two large California health systems. PLoS One. 2022; 17(8):e0273363.
Score: 0.132
-
Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 08; 70(40):1415-1419.
Score: 0.124
-
COVID-19 Inequities Across Multiple Racial and Ethnic Groups: Results From an Integrated Health Care Organization. Ann Intern Med. 2021 08; 174(8):1183-1186.
Score: 0.120
-
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization. Ann Intern Med. 2020 11 17; 173(10):773-781.
Score: 0.114
-
Antibiotic and antifungal treatment among persons with confirmed coccidioidomycosis - Southern California, 2011. Med Mycol. 2020 Apr 01; 58(3):411-413.
Score: 0.111
-
Testing for Coccidioidomycosis among Community-Acquired Pneumonia Patients, Southern California, USA1. Emerg Infect Dis. 2018 04; 24(4):779-781.
Score: 0.097
-
Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2-10 Years. Pediatr Infect Dis J. 2017 Nov; 36(11):1087-1092.
Score: 0.094
-
A Comprehensive Assessment Across the Healthcare Continuum: Risk of Hospital-Associated Clostridium difficile Infection Due to Outpatient and Inpatient Antibiotic Exposure. Infect Control Hosp Epidemiol. 2015 Dec; 36(12):1409-16.
Score: 0.081
-
Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine. J Infect Dis. 2015 Oct 15; 212(8):1222-31.
Score: 0.080
-
Incidence of polymerase chain reaction-diagnosed Clostridium difficile in a large high-risk cohort, 2011-2012. Mayo Clin Proc. 2014 Sep; 89(9):1229-38.
Score: 0.075
-
Exploring the risk factors for vaccine-associated and non-vaccine associated febrile seizures in a large pediatric cohort. Vaccine. 2014 May 07; 32(22):2574-81.
Score: 0.073
-
Ambient temperature and risk of urinary tract infection in California: A time-stratified case-crossover study using electronic health records. Environ Int. 2022 07; 165:107303.
Score: 0.032
-
Trends in Acute Myocardial Infarction by Race and Ethnicity. J Am Heart Assoc. 2020 03 03; 9(5):e013542.
Score: 0.028
-
Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-Olds. Pediatrics. 2017 01; 139(1).
Score: 0.022
-
Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease. Clin Infect Dis. 2016 Feb 15; 62(4):462-7.
Score: 0.021
-
Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol. 2014 Dec; 71(12):1506-13.
Score: 0.019
-
Vaccination against zoster remains effective in older adults who later undergo chemotherapy. Clin Infect Dis. 2014 Oct; 59(7):913-9.
Score: 0.019
-
Hepatitis B testing and vaccination among adults with sexually transmitted infections in a large managed care organization. Clin Infect Dis. 2014 Jun; 58(12):1739-45.
Score: 0.018
-
Trends and disparity in zoster vaccine uptake in a managed care population. Vaccine. 2013 Sep 23; 31(41):4564-8.
Score: 0.018